BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Catalyst Brief//FDA catalyst calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Catalyst Brief — FDA catalyst calendar
REFRESH-INTERVAL;VALUE=DURATION:PT6H
X-PUBLISHED-TTL:PT6H
BEGIN:VEVENT
UID:event-2@catalystbrief.girapphe.com
DTSTAMP:20261117T024426Z
LAST-MODIFIED:20261117T024426Z
DTSTART;VALUE=DATE:20270316
DTEND;VALUE=DATE:20270317
SUMMARY:PDUFA: Aquestive Therapeutics\, Inc. (AQST) — Anaphylm (dibutepin
 ephrine)
DESCRIPTION:FDA PDUFA goal date for Class 2 resubmission of Anaphylm sublin
 gual film NDA.\nSource: https://www.sec.gov/Archives/edgar/data/1398733/00
 0139873326000079/jefferiesglobalhealthcar.htm\nhttps://catalystbrief.girap
 phe.com/e/2?lang=en\nNot investment advice. Dates may change.
URL:https://catalystbrief.girapphe.com/e/2?lang=en
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
